2023 Clinical Practice Guidelines for Diabetes

Abstract

The Committee on Clinical Practice Guidelines of the Korean Diabetes Association updated the previous clinical practice guidelines for Korean adults with diabetes and prediabetes and published the eighth edition in May 2023. We performed a comprehensive systematic review of recent clinical trials and evidence suitable for the Korean population that could be applicable to real-world practice. These guidelines were developed to enable all healthcare providers including physicians, diabetes experts, and certified diabetes educators nationwide to best care for individuals with diabetes in a clinical practice setting. The recommendations for screening, medical nutrition therapy, pharmacologic therapy for adults with type 2 diabetes, and obesity, hypertension, and lipid management were revised and updated. The use of real-time continuous glucose monitoring (CGM) devices was recommended for adults with type 1 diabetes and adults with type 2 diabetes treated with multiple insulin injections, and additional CGM metrics were added to the blood glucose control target.